
TeleRay is an industry-first telehealth and image management platform. TeleRay cloud-based medical image management platform allows users to securely share images with professionals (specialists, referring, clinicians) and patients. The platform has many features, including the ability to import or convert DICOM or non DICOM images, query and HL7 connectivity. Integrate with any EMR, view images on an FDA approved viewer anywhere on any device.
Complete DICOM image migration is available- set up, training, and implementation is included. Live streaming and remote control of modalities are options and great for many use cases to place professionals virtually in a room any where.
TeleRay is the most secure platform with peer 2 peer health and data communication. You can use the app to access workflow tools like waiting rooms, multi-calls, call transfer and sharing of images. It's simple and affordable.
More than 3000 locations use our service, including 38 of the top medical centers in more than 20 nations. Get started today for free.
Learn more
Improve radiology reporting efficiency and report quality with Imorgon's reporting automation.
As the top DICOM SR software for radiology, our solution significantly reduces unnecessary dictation by precisely transferring ultrasound and DEXA modality measurements into Powerscribe, Fluency, or RadAI. This eliminates manual errors and significantly accelerates the generation of reports.
Imorgon's unique advantages include:
- guaranteed transfer of all measurements - usually DICOM SR
- electronic worksheets for direct report population (eliminating dictation from notes)
- worksheets with priors, calculators, and clinical decision support (TI-RADS, O-RADS, etc)
- integration with Epic and other EHRs.
- vendor-neutral
Our dedicated support team ensures uninterrupted workflow.
Invest in Imorgon for a quick and substantial return on investment, transforming your reporting overhead into a streamlined, high-quality operation.
Learn more
MIStar
Apollo Medical Imaging Technology is a pioneering software company focused on enhancing medical imaging through innovative image processing solutions tailored for both clinical and research purposes. Their leading product, MIStar, stands out as a cost-effective and user-friendly software suite that encompasses a wide range of advanced features and versatile cross-modality solutions, catering to the needs of clinicians and original equipment manufacturers alike. MIStar efficiently accommodates several imaging modalities, including CT, MR, NM, and PET, and boasts specialized modules such as CT Perfusion for stroke and various tumors, DSC-MRI for stroke analysis, DCE-MRI for tumor assessments, as well as DWI & ADC, and DTI Fiber Tractography. Additionally, it offers NM Renogram Analysis and Image Fusion capabilities, making it a comprehensive tool in medical imaging. The software also ensures seamless data management and image input via DICOM networking, complemented by an intuitive clinical database that facilitates easy anonymization and archiving of sensitive patient data. This combination of features positions MIStar as a crucial asset in modern medical imaging practices.
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based technique aimed at distinguishing areas of contrast clearance and accumulation within brain tumor imaging datasets. This advanced high-resolution analysis enhances the understanding required for ongoing evaluations and decision-making across various clinical fields, including radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The methodology entails capturing two standard 3D T1-weighted MRIs; the first scan is taken around 5 minutes after administering a standard dose of contrast agent, while the second scan occurs 60 to 105 minutes later. By subtracting the initial series from the subsequent one, volumetric maps are created that clearly identify zones of contrast clearance (shown in blue) against those of contrast accumulation (illustrated in red). These findings empower clinicians to better evaluate the effects of radiation treatment in contrast to potential tumor regrowth, allowing for more educated decisions regarding both initial and subsequent treatment plans. As a result, this analysis not only aids in clinical assessments but also enhances the overall management of patient care in complex cases.
Learn more